Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Pittrow, D; Stalla, GK; Zeiher, AM; Silber, S; März, W; Pieper, L; Klotsche, J; Glaesmer, H; Ruf, G; Schneider, HJ; Lehnert, H; Böhler, S; Koch, U; Wittchen, HU.
Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care
Med Klin (Munich). 2006; 101(8):635-644
Doi: 10.1007/s00063-006-1093-x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
- März Winfried
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND AND PURPOSE: The primary care sector is of key importance for the management of patients with diabetes mellitus. The authors investigated (a) the prevalence of diabetes mellitus type 1 and type 2, (b) the type and frequency of non-drug and drug treatment and its association with the presence of diabetic complications, and (c) the quality of metabolic control by HbA1c. METHODS: Using a nationwide probability sample of 3,188 general practices (response rate [RR] 50.6%), a total of 55,518 (RR 93.5%) patients were assessed in a prospective cross-sectional study by their physicians in September 2003 in a standardized manner using questionnaires, physician interview, and laboratory assessments. In addition to diabetes mellitus, 28 diseases were explicitly screened for, among them typical macrovascular (coronary heart disease, cerebrovascular disease, peripheral arterial disease) and microvascular disease (neuropathy, nephropathy, retinopathy, diabetic foot) complications. RESULTS: The prevalence of diabetes mellitus was 0.5% (type 1) and 14.7% (type 2), respectively. 49.5% (type 1) and 50.2% (type 2) of patients had micro- or macrovascular complications. 6.8% did not receive any treatment, 13.5% received non-drug treatment, and 75.3% received oral antidiabetic drugs and/or insulin (26.6% a combination of two or more). Compared to diabetics without any complications, treatment intensity was significantly higher in patients with microvascular complications (odds ratio [OR] 3.02), but not in those with macrovascular complications only (OR 0.98). An HbA1c value>or=7.0% was recorded in 39.6% of patients. CONCLUSION: Compared to previous studies in this setting, the proportion of diabetics with drug treatment has increased. More patients receive antidiabetic drug combinations. Quality of blood sugar control appears to have improved as well.
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Adult -
- Age Factors -
- Aged -
- Blood Glucose - analysis
- Cardiovascular Diseases - epidemiology
- Clinical Trials as Topic - epidemiology
- Cross-Sectional Studies - epidemiology
- Diabetes Complications - epidemiology
- Diabetes Mellitus - blood
- Diabetes Mellitus, Type 1 - blood
- Diabetes Mellitus, Type 2 - blood
- Family Practice - blood
- Female - blood
- Hemoglobin A, Glycosylated - analysis
- Humans - analysis
- Hypoglycemic Agents - administration and dosage
- Logistic Models - administration and dosage
- Male - administration and dosage
- Middle Aged - administration and dosage
- Odds Ratio - administration and dosage
- Prevalence - administration and dosage
- Primary Health Care - administration and dosage
- Prospective Studies - administration and dosage
- Risk Factors - administration and dosage
- Sex Factors - administration and dosage
- Time Factors - administration and dosage
- Find related publications in this database (Keywords)
- epidemiology
- diabetes mellitus
- complications
- cardiovascular risk
- HbA(1c)
- primary care